2-month minimum commitment
First author of the meta-analysis, Andr Saad, a medical student at the State University of Ponta Grossa in Paran, Brazil, told Medical News Today that: Weight loss is closely related to improved cardiovascular health, especially in patients who have developed heart failure
Based on current evidence, including the Medicines and Healthcare products Regulatory Agency (MHRA) Summary of Product Characteristics, there is no known clinically significant effect of Mounjaro on potassium levels
Individual biological variation in GLP-1 receptor sensitivity, metabolism, and hormonal regulation means that not everyone responds identically to the medication
Monier, I
Graphical abstract Similar content being viewed by others Introduction SGLT2i are a class of medications originally employed in treatment of T2DM